Kwang Woo Ahn, PhD

Publications

• Allogeneic Transplant Conditioning Regimens for Patients With Non-Hodgkin Lymphoma-Reply.

  (Hamadani M, Litovich C, Ahn KW.) JAMA Oncol. 2020 Dec 01;6(12):1984 PMID: 33151256 SCOPUS ID: 2-s2.0-85095867531 11/06/2020

• Timing of allogeneic hematopoietic cell transplantation (alloHCT) for chronic myeloid leukemia (CML) patients.

  (Hu B, Lin X, Lee HC, Huang X, Tidwell RSS, Ahn KW, Hu ZH, Jabbour E, Verstovsek S, Ravandi F, Garcia-Manero G, Kharfan-Dabaja MA, Hossain NM, Marks DI, Kamble RT, Inamoto Y, Kindwall-Keller T, Saad A, Litzow MR, Savani BN, Hale GA, Bacher U, Gerds AT, Liesveld JL, Ustun C, Olsson RF, Daly A, Grunwald MR, Solh M, DeFilipp Z, Aljurf M, Wirk B, Akpek G, Nishihori T, Cerny J, Seo S, Hsu JW, Champlin R, de Lima M, Alyea E, Popat U, Sobecks R, Scott BL, Kantarjian H, Cortes J, Saber W.) Leuk Lymphoma. 2020 12;61(12):2811-2820 PMID: 32662346 SCOPUS ID: 2-s2.0-85089288816 07/15/2020

• Is Autologous Transplant in Relapsed DLBCL Patients Achieving Only a PET+ PR Appropriate in the CAR-T cell Era?

  (Shah NN, Ahn KW, Litovich CA, He Y, Sauter CS, Fenske TS, Hamadani M.) Blood. 2020 Oct 29 PMID: 33120429 10/30/2020

• Statistical Methods for Time-Dependent Variables in Hematopoietic Cell Transplantation Studies.

  (Kim S, Logan B, Riches M, Chen M, Ahn KW.) Biol Blood Marrow Transplant. 2020 Oct 02 PMID: 33017663 SCOPUS ID: 2-s2.0-85093960710 10/06/2020

• Impact of Reduced-Intensity Conditioning Regimens on Outcomes in Diffuse Large B Cell Lymphoma Undergoing Allogeneic Transplantation.

  (Epperla N, Ahn KW, Khanal M, Litovich C, Ahmed S, Ghosh N, Fenske TS, Kharfan-Dabaja MA, Sureda A, Hamadani M.) Biol Blood Marrow Transplant. 2020 Sep 19 PMID: 32956819 SCOPUS ID: 2-s2.0-85093981145 09/22/2020

• Impact of type of reduced-intensity conditioning regimen on the outcomes of allogeneic haematopoietic cell transplantation in classical Hodgkin lymphoma.

  (Ahmed S, Ghosh N, Ahn KW, Khanal M, Litovich C, Mussetti A, Chhabra S, Cairo M, Mei M, William B, Nathan S, Bejanyan N, Olsson RF, Dahi PB, van der Poel M, Steinberg A, Kanakry J, Cerny J, Farooq U, Seo S, Kharfan-Dabaja MA, Sureda A, Fenske TS, Hamadani M.) Br J Haematol. 2020 Aug;190(4):573-582 PMID: 32314807 PMCID: PMC7575614 SCOPUS ID: 2-s2.0-85083643436 04/22/2020

• Association of Reduced-Intensity Conditioning Regimens With Overall Survival Among Patients With Non-Hodgkin Lymphoma Undergoing Allogeneic Transplant.

  (Ghosh N, Ahmed S, Ahn KW, Khanal M, Litovich C, Aljurf M, Bacher VU, Bredeson C, Epperla N, Farhadfar N, Freytes CO, Ganguly S, Haverkos B, Inwards D, Kamble RT, Lazarus HM, Lekakis L, Murthy HS, Nishihori T, Ramakrishnan P, Rizzieri DA, Yared JA, Kharfan-Dabaja MA, Sureda A, Hamadani M.) JAMA Oncol. 2020 Jul 01;6(7):1011-1018 PMID: 32496525 PMCID: PMC7273311 SCOPUS ID: 2-s2.0-85086233103 06/05/2020

• Comparison of total body irradiation versus non- total body irradiation containing regimens for de novo acute myeloid leukemia in children.

  (Dandoy CE, Davies SM, Ahn KW, He Y, Kolb AE, Levine J, Bo-Subait S, Abdel-Azim H, Bhatt N, Chewing J, Gadalla S, Gloude N, Hayashi R, Lalefar NR, Law J, MacMillan M, O'Brien T, Prestidge T, Sharma A, Shaw P, Winestone L, Eapen M.) Haematologica. 2020 Jun 18 PMID: 32554562 SCOPUS ID: 2-s2.0-85086742043 06/20/2020

• Investigating the Trajectory of the COVID-19 Outbreak in Milwaukee County and Projected Effects of Relaxed Distancing.

  (Bemanian A, Ahn KW, O'Brien M, Rausch DJ, Weston B, Beyer KMM.) WMJ. 2020 Jun;119(2):84-90 PMID: 32659059 SCOPUS ID: 2-s2.0-85088027487 07/14/2020

• Higher Total Body Irradiation Dose Intensity in Fludarabine/TBI-Based Reduced-Intensity Conditioning Regimen Is Associated with Inferior Survival in Non-Hodgkin Lymphoma Patients Undergoing Allogeneic Transplantation.

  (Hamadani M, Khanal M, Ahn KW, Litovich C, Chow VA, Eghtedar A, Karmali R, Winter A, Fenske TS, Sauter C, Kharfan-Dabaja MA, Awan FT.) Biol Blood Marrow Transplant. 2020 06;26(6):1099-1105 PMID: 32165327 PMCID: PMC7255948 SCOPUS ID: 2-s2.0-85083523089 03/14/2020

• Survival following allogeneic transplant in patients with myelofibrosis.

  (Gowin K, Ballen K, Ahn KW, Hu ZH, Ali H, Arcasoy MO, Devlin R, Coakley M, Gerds AT, Green M, Gupta V, Hobbs G, Jain T, Kandarpa M, Komrokji R, Kuykendall AT, Luber K, Masarova L, Michaelis LC, Patches S, Pariser AC, Rampal R, Stein B, Talpaz M, Verstovsek S, Wadleigh M, Agrawal V, Aljurf M, Angel Diaz M, Avalos BR, Bacher U, Bashey A, Beitinjaneh AM, Cerny J, Chhabra S, Copelan E, Cutler CS, DeFilipp Z, Gadalla SM, Ganguly S, Grunwald MR, Hashmi SK, Kharfan-Dabaja MA, Kindwall-Keller T, Kröger N, Lazarus HM, Liesveld JL, Litzow MR, Marks DI, Nathan S, Nishihori T, Olsson RF, Pawarode A, Rowe JM, Savani BN, Savoie ML, Seo S, Solh M, Tamari R, Verdonck LF, Yared JA, Alyea E, Popat U, Sobecks R, Scott BL, Nakamura R, Mesa R, Saber W.) Blood Adv. 2020 05 12;4(9):1965-1973 PMID: 32384540 PMCID: PMC7218417 SCOPUS ID: 2-s2.0-85086108920 05/10/2020

• Pacemaker detected active minutes are superior to pedometer-based step counts in measuring the response to physical activity counseling in sedentary older adults.

  (Puppala VK, Hofeld BC, Anger A, Tyagi S, Strath SJ, Fox J, Berger MG, Ahn KW, Widlansky ME.) BMC Geriatr. 2020 05 06;20(1):162 PMID: 32375676 PMCID: PMC7201960 SCOPUS ID: 2-s2.0-85084386697 05/08/2020